After a recent, highly public failure in regulatory oversight of genetically engineered crop development, a new coalition has formed to push the USDA to review the activities of agricultural biotechnology companies with a keener eye. Watch this video to find out what the issues are, and what this new development might mean for companies.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
A new coalition may have the clout to force USDA's hand on ag biotech oversight.
About the Author
Sara has been writing about and analyzing companies from a sustainable investment perspective for the last 15 years. An ardent optimist, she believes that it is entirely possible for all stakeholders to benefit and profit from companies' ingenuity and innovation.
Sara Murphy has no position in any stocks mentioned. Follow her on Twitter @SMurphSmiles. The Motley Fool recommends Scotts Miracle-Gro. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
Monsanto Company
MON
The Dow Chemical Company
DOW
Scotts Miracle-Gro
SMG
$62.23
(-8.30%)
$-5.63
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Why SolarEdge Technologies Stock Is Burning Brightly in Investors' Eyes Today
Why Oklo Stock Is Charging Higher Today
Should You Buy Energy Transfer (ET) Stock Before Aug. 6? Here's What History Says.
3 Reasons to Be Very, Very Excited About Rocket Lab Stock Right Now
Why AST SpaceMobile Stock Has Been Quietly Crushing the Market Lately
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.